[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Emre Şenocak\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":175},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,45,72,102,128,153],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100612133","a-biopsychosocial-based-multimodal-approach-to-reducing-the-risk-of-delirium-in-icu-100612133",false,"NCT07249619","A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU","A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in Patients With Subarachnoid Hemorrhage in the Intensive Care Unit (ICU.Delibma)","Inclusion Criteria:\n\n* Aged 18-85,\n* Patients scheduled for intensive care for at least 15 days due to SAH, unruptured intracranial aneurysm, and\u002For Arterovenous Malformation,\n* Those with a Mini Mental State Examination score of \\> 24,\n* Those with a Glasgow Coma Score of 15,\n* Those with motor function in at least one extremity,\n* Those with pain \\\u003C 5\u002F10 (according to the NRS)\n\nExclusion Criteria:\n\n* Patients whose GCS fell to 14 or below for any reason during the study period;\n* Patients who developed septic shock and MODS;\n* Patients requiring endotrachial intubation and mechanical ventilation due to ARDS;\n* Those requiring vasopressors such as NE at a rate of \\>0.25 mcg\u002Fkg\u002Fmin;\n* Terminal cancer cases;\n* Patients with advanced chronic heart and lung failure and COPD;\n* Those with a METS (exercise capacity) of \\\u003C4;\n* Those with a history of dementia, Alzheimer's disease, or psychiatric illness;\n* Those with vision, hearing, or speech problems that would interfere with communication;\n* Those with a history of epilepsy;","ALL","18 Years","85 Years",{"count":20,"type":21},34,"ESTIMATED","INTERVENTIONAL",[24],"NA","As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered.\n\nPatients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.",[27],"Subarachnoid Haemorrhagic Stroke",[29,30,31],"Body Awareness Therapy","Communication","Delirium","NOT_YET_RECRUITING","2025-11-18",{"date":35,"type":36},"2025-11-25","ACTUAL",{"date":38,"type":21},"2026-01-02",{"date":40,"type":21},"2028-01-02",{"name":42,"class":43},"Emre Şenocak","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},"100553426","kinesiophobia-scale-for-the-upper-extremity-100553426","NCT06485934","Kinesiophobia Scale for the Upper Extremity","Development of the Multidimensional Kinesiophobia Scale for the Upper Extremity: A Scale Development Study","Inclusion Criteria:\n\n* Tampa Kinesiophobia Score \\>37 points\n* Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity\n* Mini-Mental State Examination score \\>24 points\n\nExclusion Criteria:\n\n* Malignancy,\n* Psychiatric drug use,\n* Use of painkillers during evaluation periods,\n* Those who received physiotherapy before the study (last 6 months),\n* Those whose education level is below secondary school level,","65 Years",{"count":54,"type":21},150,"OBSERVATIONAL","Questionnaires\u002Fscales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems.\n\nThe study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.",[58],"Shoulder Injuries",[60,61,62],"Kinesiophobia","Shoulder","Development of Scale","RECRUITING",{"date":65,"type":36},"2025-11-19",{"date":67,"type":36},"2024-07-22",{"date":69,"type":21},"2026-06-01",{"name":42,"class":43},2,{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":16,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":83,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":44},"100605833","median-nerve-thickness-of-the-carpal-tunnel-syndrome-after-two-different-physiotherapy-modalities-100605833","NCT07167667","Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities","Investigation of the Effects of Two Different Physiotherapy Modalities on Median Nerve Thickness, Electrophysiological Activity, Pain Intensity and Quality of Life in Patients With Carpal Tunnel Syndrome - An Observational Study","Inclusion Criteria:\n\n* Individuals between the ages of 30-60 who have been diagnosed with CTS by a specialist physician according to international criteria (Those between Stages 1-3),\n* Those who have complaints of numbness, tingling, and pain in the first three fingers and half of the fourth finger,\n* Phalen Test and Tinel sign or Durkan Test being positive\n* Patients who will receive 5 sessions of ESWT application prescribed by a Physical Medicine and Rehabilitation Specialist Physician (for the ESWT group)\n* Patients who have been recommended 10 sessions of Paraffin application by a Physical Medicine and Rehabilitation Specialist Physician (for the Paraffin group)\n\nExclusion Criteria:\n\n* Presence of atrophy in the thenar muscles,\n* Insufficient sensory and motor response in the median nerve,\n* History of hand and\u002For wrist injury or surgery,\n* Those with cervical stenosis, cervical spondylosis, or cervical radiculopathy,\n* Corticosteroids in the carpal tunnel area within the last six months those who have had an injection,\n* Pregnancy or diabetes, renal failure, rheumatoid arthritis or hypothyroidism","30 Years","60 Years",{"count":82,"type":21},60,[24],"The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools;\n\n* Measurement of median nerve thickness with ultrasound\n* Electromyography\n* Visual Analog Scale\n* Short Form-36\n\nEvaluations will be made twice by a specialist physician before and after the treatments.",[86],"Carpal Tunnel Syndrome (CTS)",[88,89,90,91,92,93],"Median Nerve Thickness","Ultrasound","Electromyograpy","Physiotherapy","ESWT","Paraffin","2025-09-09",{"date":96,"type":36},"2025-09-11",{"date":98,"type":36},"2024-10-25",{"date":100,"type":21},"2025-10-25",{"name":42,"class":43},{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":4,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":16,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":112,"studyType":55,"phases":4,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":44},"100553162","validity-of-the-6-minute-pegboard-and-ring-test-in-parkinsons-patients-100553162","NCT06482502","Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients","Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments","Inclusion Criteria:\n\n* Hoehn \\& Yahr staging ≤3 points,\n* Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months,\n* Those with full upper extremity shoulder flexion and abduction active joint range of motion.\n\nExclusion Criteria:\n\n* Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension,\n* People with any orthopedic problem that will affect the upper extremity,\n* Having a secondary neurological disease diagnosis,\n* Having vision impairment that may affect measurement methods (not corrected by glasses),\n* Having a cognitive disease that may cause difficulty in following the researchers\\' commands,\n* Those who had changes in their medical use during the test (dose increase\u002Fdecrease, drug change","45 Years","75 Years",{"count":20,"type":21},"2 Days","Tests used to assess upper extremity endurance in Parkinson\\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.",[115],"Parkinson Disease",[117,118,119],"Parkinson","Validity","6-Minute Pegboard and Ring Test","2025-03-06",{"date":122,"type":36},"2025-03-07",{"date":124,"type":36},"2024-05-20",{"date":126,"type":21},"2025-12-31",{"name":42,"class":43},{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":16,"minAge":135,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":22,"phases":139,"briefSummary":140,"conditions":141,"keywords":142,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":44},"100553801","minimal-clinically-important-difference-of-the-box-and-block-test-in-parkinson-100553801","NCT06490809","Minimal Clinically Important Difference of the Box and Block Test in Parkinson","Examining the Clinical Significance of the Change in Manual Dexterity of Parkinson's Patients Receiving Conventional Physiotherapy","Inclusion Criteria:\n\n* Being Hoehn \\& Yahr Stage between 1-3,\n* Individuals in the \"On\" phase,\n* Those who were not exposed to any physiotherapy intervention during the initial assessment\n\nExclusion Criteria:\n\n* Mini-mental status assessment \\< 24 points;\n* Presence of severe dyskinesia,\n* Those who experience fluctuations in the on-off phase,\n* Those who have undergone stereotaxic brain surgery for Parkinson's,\n* Individuals with changes in dopamine dose within three months,\n* Presence of unstable cardiac and respiratory disease\n* Those with an orthopedic problem or a history of surgery affecting upper extremity performance.","50 Years","80 Years",{"count":138,"type":21},44,[24],"The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful.\n\nPatients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist.\n\nUpper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.",[115],[117,143,144],"Box and Block Test","Minimal Clinically Important Difference","2025-03-04",{"date":147,"type":36},"2025-03-05",{"date":149,"type":36},"2024-10-01",{"date":151,"type":21},"2025-08-01",{"name":42,"class":43},{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":4,"eligibilityCriteria":159,"healthyVolunteers":11,"sex":16,"minAge":160,"maxAge":136,"enrollmentInfo":161,"targetDuration":163,"studyType":55,"phases":4,"briefSummary":164,"conditions":165,"keywords":166,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":169,"startDateStruct":170,"completionDateStruct":172,"leadSponsor":174,"locationsCount":44},"100553536","determination-of-the-minimal-detectable-change-of-the-parkinsons-disease-questionnaire-8-100553536","NCT06487364","Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8","Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8","Inclusion Criteria:\n\n* Having regular neurology follow-up and using medicine;\n* Hoehn and Yahr Scale Stage between 1-3 points;\n* Mini-Mental State Assessment Score \\>24 points;\n\nExclusion Criteria:\n\n* Having a secondary neurological disease;\n* Any surgery and\u002For trauma affecting the upper extremity\n* Having complaints of pain before the treatment program;\n* There was a change in medical treatment during the study;\n* With symptoms of anxiety and depression;\n* Those who use alcohol and drugs;\n* Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss","40 Years",{"count":162,"type":21},39,"30 Days","This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.",[115],[117,167,144,168],"Minimal Detectable Change","Parkinson Disease Questionnaire-8",{"date":147,"type":36},{"date":171,"type":36},"2024-05-13",{"date":173,"type":21},"2025-09-17",{"name":42,"class":43},""]